Rheos Medicines
PrivateCompany Overview
Rheos Medicines was a biopharmaceutical company that developed precision medicines for autoimmune and inflammatory diseases by targeting the metabolic pathways of immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
precision medicinedrug discoverymetabolomicsimmunologysmall moleculebiotechautoimmune diseasemetabolic pathwaysbiomarker discoverycomputational biologyai drug discoveryin silico drug discoverymulti-omicstherapeutic targetsimmune homeostasis
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheos Medicines Comparables
Compare Rheos Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 84% | |
| META Pharmaceuticals Inc. | 82% | |
| Immunai | 78% | |
Rheos Medicines Funding Rounds
Historical fundraising activity
Rheos Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rheos Medicines's valuation, stock price, and market status.